SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006769
Filing Date
2018-08-08
Accepted
2018-08-08 16:31:30
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q osir-20180630x10q.htm 10-Q 1292193
2 EX-31.1 osir-20180630ex311607864.htm EX-31.1 16795
3 EX-31.2 osir-20180630ex312878bad.htm EX-31.2 16506
4 EX-32.1 osir-20180630ex321feb3f5.htm EX-32.1 11922
  Complete submission text file 0001558370-18-006769.txt   5648282

Data Files

Seq Description Document Type Size
5 EX-101.INS osir-20180630.xml EX-101.INS 1562478
6 EX-101.SCH osir-20180630.xsd EX-101.SCH 30092
7 EX-101.CAL osir-20180630_cal.xml EX-101.CAL 48755
8 EX-101.DEF osir-20180630_def.xml EX-101.DEF 67410
9 EX-101.LAB osir-20180630_lab.xml EX-101.LAB 265525
10 EX-101.PRE osir-20180630_pre.xml EX-101.PRE 184230
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 181001830
SIC: 2836 Biological Products, (No Diagnostic Substances)